Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial adrenoceptors.

P M Vanhoutte1

  • 1Institut de Recherches Internationales Servier, Courbevoie, France.

Journal of Cardiovascular Pharmacology
|October 17, 2001
PubMed
Summary
This summary is machine-generated.

Alpha2-adrenergic agonists promote blood vessel relaxation via endothelial nitric oxide. This effect is diminished in regenerated or atherosclerotic arteries, suggesting impaired endothelial function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelium-derived relaxing factors and converting enzyme inhibition.

The American journal of cardiology·1995
Same author

[Vascular endothelium and vasomotor tonus].

Revue medicale de Liege·1995
Same author

Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells.

Molecular pharmacology·1994
Same author

Inducible nitric oxide synthase in vascular smooth muscle.

Arzneimittel-Forschung·1994
Same author

Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells.

Circulation research·1994
Same author

Nomenclature of calcium channels and channel modulators: IUPHAR classification.

Journal of cardiovascular pharmacology·1993
Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026
Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
See all related articles

Area of Science:

  • Cardiovascular Pharmacology
  • Endothelial Function
  • Adrenergic Signaling

Background:

  • Alpha2-adrenergic agonists induce endothelium-dependent relaxation through nitric oxide synthase activation.
  • This response is compromised in regenerated endothelium and atherosclerotic arteries.
  • Beta-adrenergic agonists also cause relaxation, but their endothelial role is debated.

Purpose of the Study:

  • To investigate the role of endothelial alpha2- and beta-adrenergic receptors in blood vessel relaxation.
  • To understand the mechanisms underlying blunted responses in certain vascular conditions.
  • To clarify the contribution of endothelial beta-adrenoceptors to vasodilation.

Main Methods:

  • Studies on isolated blood vessels and intact animal/human forearm models.

Related Experiment Videos

  • Assessment of endothelium-dependent relaxation.
  • Inhibition of nitric oxide synthase pathways.

    • Main Results:

    • Alpha2-adrenergic agonists cause endothelium-dependent relaxation linked to nitric oxide.
    • Endothelial responses to alpha2-agonists are reduced in regenerated and atherosclerotic arteries.
    • Beta-adrenergic agonist-induced vasodilation is endothelium-dependent and nitric oxide-mediated, but functional endothelial beta-adrenoceptors remain controversial.

    Conclusions:

    • Endothelial alpha2-adrenoceptors play a role in nitric oxide-mediated relaxation.
    • Vascular conditions like atherosclerosis impair this endothelial function.
    • The presence and function of endothelial beta-adrenoceptors are not definitively established despite observed relaxation effects.